Mitochondrial aspartate aminotransferase catalyses cysteine S-conjugate β-lyase reactions

被引:29
作者
Cooper, AJL [1 ]
Bruschi, SA
Iriarte, A
Martinez-Carrion, M
机构
[1] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA
[3] Burke Med Res Inst, White Plains, NY 10605 USA
[4] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA
[5] Univ Missouri, Sch Biol Sci, Dept Mol Biol & Biochem, Kansas City, MO 64110 USA
关键词
halogenated alkenes; mitochondrial toxicity; S-(1,2-dichlorovinyl)-L-Cysteine; S-(1,1,2,2-tetrafluoroethyl)-L-cysteine; thioacylating fragments;
D O I
10.1042/BJ20020531
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rat liver mitochondrial aspartate aminotransferase (a homodimer) was shown to catalyse a beta-lyase reaction with three nephrotoxic halogenated cysteine S-conjugates [S-(1,1,2,2-tetrafluoroethyl)-L-cysteine, S-(1,2-dichlorovinyl)-L-cysteine and S-(2-chloro-1,1,2-trifluoroethyl)-L-Cysteine], and less effectively so with a non-toxic cysteine S conjugate [benzothiazolyi-L-cysteine]. Transamination competes with the beta-lyase reaction, but is not favourable. The ratio of elimination to transamination in the presence of S-(1,1,2,2-tetrafluoroethyl)-L-cysteine and 2-oxoglutarate is > 100. Syncatalytic inactivation by the halogenated cysteine S-conjugates is also observed. The enzyme turns over approx. 2700 molecules of halogenated cysteine S-conjugate on average for every monomer inactivated. Kidney mitochondria are known to be especially sensitive to toxic halogenated cysteine S-conjugates. Evidence is presented that 15-20 % of the cysteine S-conjugate beta-lyase activity towards S-(1,1,2,2-tetrafluoroethyl)L-Cysteine in crude kidney mitochondrial homogenates is due to mitochondrial aspartate aminotransferase. The possible involvement of mitochondrial aspartate aminotransferase in the toxicity of halogenated cysteine S-conjugates is also discussed.
引用
收藏
页码:253 / 261
页数:9
相关论文
共 47 条
[1]   Novel sources of mammalian C-S lyase activity [J].
Adcock, HJ ;
Gaskin, PJ ;
Shaw, PN ;
TeesdaleSpittle, PH ;
Buckberry, LD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (02) :150-153
[2]   Glutathione-dependent bioactivation of haloalkenes [J].
Anders, MW ;
Dekant, W .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1998, 38 :501-537
[3]   Mitochondrial stress protein recognition of inactivated dehydrogenases during mammalian cell death [J].
Bruschi, SA ;
Lindsay, JG ;
Crabb, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13413-13418
[4]  
BRUSCHI SA, 1993, J BIOL CHEM, V268, P23157
[5]   Cysteine conjugate β-lyase activity of amino acid decarboxylases. [J].
Buckberry, LD ;
Patel, R ;
Hollingworth, L ;
Teesdale-Spittle, PH .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1998, 26 (03) :S269-S269
[6]   CYSTEINE CONJUGATE TOXICITY IN A HUMAN CELL-LINE - CORRELATION WITH C-S LYASE ACTIVITY IN HUMAN HEPATIC TISSUE [J].
BUCKBERRY, LD ;
BLAGBROUGH, IS ;
SHAW, PN .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1993, 12 (04) :329-335
[7]   PROTECTIVE EFFECT OF THIOSULFATE UPON INACTIVATION OF ASPARTATE AMINOTRANSFERASE BY AMINOACRYLIC-ACID-PRODUCING SUBSTRATES [J].
CAVALLIN.D ;
FEDERICI, G ;
BOSSA, F ;
GRANATA, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1973, 39 (01) :301-304
[8]  
Cechetto JD, 2002, HISTOL HISTOPATHOL, V17, P353, DOI 10.14670/HH-17.353
[9]   DISTRIBUTION OF 2 AMINOTRANSFERASES AND D-AMINO-ACID OXIDASE WITHIN THE NEPHRON OF YOUNG AND ADULT-RATS [J].
CHAN, AWK ;
PERRY, SG ;
BURCH, HB ;
FAGIOLI, S ;
ALVEY, TR ;
LOWRY, OH .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1979, 27 (03) :751-755
[10]   NEPHROTOXICITY OF MERCAPTURIC ACIDS OF 3 STRUCTURALLY RELATED 2,2-DIFLUOROETHYLENES IN THE RAT - INDICATIONS FOR DIFFERENT BIOACTIVATION MECHANISMS [J].
COMMANDEUR, JNM ;
BRAKENHOFF, JPG ;
DEKANTER, FJJ ;
VERMEULEN, NPE .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (23) :4495-4504